⚙️ Technology

Metformin

1 story First seen Jul 19, 2026 Latest Jul 19, 2026

🧬 AI profile — grown from 6ic coverage Metformin is a widely prescribed oral antidiabetic medication primarily used to treat type 2 diabetes. It has been explored in recent studies for its potential off-label use in treating Long COVID symptoms, particularly fatigue. Researchers are investigating whether metformin's anti-inflammatory properties can help alleviate Long COVID-related fatigue.

Coverage by desk

Science 1

Coverage · last 14 days

Jul 7Jul 20

Recurring themes

long COVID ×1 fluvoxamine ×1 McMaster University ×1 Brazil ×1 clinical trial ×1

🕸 Connection map 🌌 Full galaxy →

Connected entities

Stanford University ×1 REVIVE-TOGETHER ×1 McMaster University ×1 Brazil ×1 COVID ×1 University of British Columbia ×1 SARS-CoV-2 ×1 Brazilian ×1 Fluvoxamine ×1

Every story (1)

Breakthrough in Long COVID Treatment: Fluvoxamine Shows Promise in Reducing Fatigue

Science · Jul 19, 2026 · BlockchainSpace AI